Legislation & Regulation

Medicaid VBPs for Patients Act (MVP Act)
Press Releases

AMCP Welcomes Reintroduction of the Medicaid VBPs for Patients Act to Expand Medicaid Access to Novel Therapies

AMCP applauds the House reintroduction of the Medicaid VBPs for Patients (MVP) Act (H.R. 7871) by Rep. Brett Guthrie (KY-02) alongside Rep. Jake Auchincloss (MA-04), Rep. Mariannette Miller-Meeks (IA-01), Rep. John Joyce (PA-13), Rep. Scott Peters (CA-50), and Rep. Don Davis (NC-01). This bipartisan legislation complements Senate bill S. 1637 and aims to improve patient access to novel therapies by enhancing the use of value-based purchasing arrangements in Medicaid.
Drug Pricing, Legislation & Regulation
Legislative & Regulatory Position

Regulation of the Prescription Drug Benefit

AMCP opposes statutory and regulatory proposals that unduly restrict the ability of pharmacists working within managed care organizations from utilizing tools and services that are essential for the management of a prescription drug benefitFind out about Regulation of the Prescription Drug Benefit.
Formulary & Utilization Management, Prior Authorization/Electronic Prior Authorization (ePA), Legislation & Regulation, Step Therapy